Tirzepatide vs Semaglutide Cost Comparison: Brand and Compounded Pricing
By FormBlends Medical Team · Last updated: April 3, 2026
From a pure cost perspective, compounded semaglutide is generally the cheapest GLP-1 option at $200-350 per month. Compounded tirzepatide runs slightly higher at $250-400. Brand versions of both are similarly expensive at $900-1,500. The cost-effectiveness calculation depends on individual response: if tirzepatide produces faster or greater results, the slight premium may be worthwhile. For budget-conscious patients, compounded semaglutide offers the best price-to-efficacy ratio.
How to Use This Comparison
Use this comparison as a decision aid, not a prescription shortcut. Compounded semaglutide is $50-100/month cheaper than compounded tirzepatide on average. Tirzepatide (All Forms) is usually a better fit for people who prioritize maximum weight loss efficacy and are willing to pay a slight premium for the dual-action mechanism, while Semaglutide (All Forms) is usually a better fit for people who want the most affordable glp-1 option, especially in compounded form, with proven efficacy. Cost also matters: Tirzepatide (All Forms) is listed at $250-400/month compounded, $1,000-1,500/month brand, while Semaglutide (All Forms) is listed at $200-350/month compounded, $900-1,500/month brand. Because this comparison is framed as an either-or decision, the safety question is which option fits your health history, side-effect tolerance, and access path.
FormBlends Comparison Context
Reviewed May 14, 2026The strongest way to read Tirzepatide Vs Semaglutide Cost comparison is to look for what changes the next step. For GLP-1 treatment, cost and access, provider comparison, that means checking whether the page is explaining evidence, eligibility, cost, safety, provider fit, or day-to-day use. The goal is not more words on the page. It is a clearer path from a broad question to a responsible medical conversation.
- Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
- Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
- Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.
PubMed evidence trail
Research sources used to frame this page
For Tirzepatide vs Semaglutide Cost Comparison: Brand and Compounded Pricing, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
Tirzepatide vs Semaglutide Cost Comparison: Brand and Compounded Pricing should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
Head-to-Head Comparison
Tirzepatide (All Forms)
GLP-1
Strengths
- Higher average weight loss may mean better value per pound lost
- Dual mechanism may reduce overall treatment duration for some patients
- Compounded versions are increasingly available
- Brand versions (Mounjaro/Zepbound) have manufacturer savings programs
Weaknesses
- Compounded tirzepatide is slightly more expensive than compounded semaglutide
- Brand pricing is comparable to brand semaglutide
- Compounded regulatory status is less settled
- Fewer compounding pharmacies currently offer tirzepatide
Best For
People who prioritize maximum weight loss efficacy and are willing to pay a slight premium for the dual-action mechanism.
Typical Cost
$250-400/month compounded, $1,000-1,500/month brand
Semaglutide (All Forms)
GLP-1
Strengths
- Compounded versions are widely available and slightly cheaper
- More compounding pharmacies produce semaglutide
- Brand versions have more established insurance coverage pathways
- Longer market history means more competitive pricing
Weaknesses
- Lower average weight loss compared to tirzepatide
- Single GLP-1 mechanism vs dual mechanism
- Brand pricing remains very high without insurance
Best For
People who want the most affordable GLP-1 option, especially in compounded form, with proven efficacy.
Typical Cost
$200-350/month compounded, $900-1,500/month brand
Key Differences
- 1Compounded semaglutide is $50-100/month cheaper than compounded tirzepatide on average
- 2Brand pricing for both is similar at $900-1,500/month
- 3Tirzepatide may offer better cost-per-pound-lost due to higher efficacy
- 4Semaglutide has more compounding pharmacy availability and competition
- 5Insurance coverage pathways are more established for brand semaglutide
- 6Manufacturer savings cards can reduce brand costs significantly for eligible patients
Frequently Asked Questions
What is the difference between Tirzepatide (All Forms) and Semaglutide (All Forms)?
Compounded semaglutide is $50-100/month cheaper than compounded tirzepatide on average. Brand pricing for both is similar at $900-1,500/month.
Which is more effective, Tirzepatide (All Forms) or Semaglutide (All Forms)?
From a pure cost perspective, compounded semaglutide is generally the cheapest GLP-1 option at $200-350 per month. Compounded tirzepatide runs slightly higher at $250-400. Brand versions of both are similarly expensive at $900-1,500. The cost-effectiveness calculation depends on individual response: if tirzepatide produces faster or greater results, the slight premium may be worthwhile. For budget-conscious patients, compounded semaglutide offers the best price-to-efficacy ratio.
How much does Tirzepatide (All Forms) cost compared to Semaglutide (All Forms)?
Tirzepatide (All Forms) typically costs $250-400/month compounded, $1,000-1,500/month brand, while Semaglutide (All Forms) typically costs $200-350/month compounded, $900-1,500/month brand.
Who should choose Tirzepatide (All Forms) over Semaglutide (All Forms)?
Tirzepatide (All Forms) is best for: People who prioritize maximum weight loss efficacy and are willing to pay a slight premium for the dual-action mechanism.. Semaglutide (All Forms) is best for: People who want the most affordable GLP-1 option, especially in compounded form, with proven efficacy..
Ready to get started?
Connect with a licensed provider who can help you decide between Tirzepatide (All Forms) and Semaglutide (All Forms) based on your goals, health history, and budget.